RELEASE: Leading Biopharmaceutical Companies Elevate Medical Commitment with Veeva Link Scientific Awareness

(Information sent by the signatory company).

RELEASE: Leading Biopharmaceutical Companies Elevate Medical Commitment with Veeva Link Scientific Awareness

(Information sent by the signatory company)

Leading companies leverage real-time insights into scientific voice engagement and product sentiment to drive more relevant medical communications

BARCELONA, Spain, Nov. 23, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) announced today that three of the top ten biopharmaceuticals now use the recently launched Veeva Link Scientific Awareness to gain real-time intelligence on awareness and sentiment of the product. Veeva Link Scientific Awareness provides key success metrics across scientific, digital and social channels to help medical teams optimize product strategy and effectively educate the scientific and medical community on different treatments.

"Medical teams are shifting from volume-based activity metrics to value-based standards that show the external impact of medical activities among the scientific and clinical community," said Zijian Zhao, global director of medical portfolio strategy at Novartis. "Veeva Link Scientific Awareness helps us quickly assess product awareness across all channels to lead engagements that strengthen relationships and better serve patients."

Veeva Link Scientific Awareness is part of the Veeva Link family of products, a modern data platform that combines intelligent software automation with human curation to ensure accuracy and depth. This helps Veeva Link deliver real-time intelligence in an increasing number of areas, including sales, medical, marketing, and clinical. Available in 87 countries, the application analyzes data from more than 300,000 medical congresses and 100 million social publications, selected by more than 1,000 specialists and validated by more than 100 doctors.

"Real-time intelligence is critical to understanding the evolving healthcare ecosystem and tailoring engagements with scientific experts to meet your specific needs across therapeutic areas," said Kilian Weiss, CEO of Veeva Link. "Veeva Link Scientific Awareness helps medical teams guide more effective communications that deepen product understanding so patients and clinicians are better informed in today's on-demand digital world."

At Veeva Commercial Summit Europe in Madrid on November 28-30, 2022, Novartis and others will share how they are leveraging Link Scientific Awareness in their organizations to elevate expert engagement. Professionals in the life sciences industry can register at

Additional Information

For more information on Veeva Link Scientific Awareness, visit:

Contact Veeva on LinkedIn:

About Veeva Systems

Veeva is the world leader in cloud software for the life sciences industry. Committed to innovation, product excellence and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechnologies. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit

Veeva Forward-Looking Statements

This release contains forward-looking statements about Veeva's products and services and the expected results or benefits from the use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we are under no obligation to update such statements. There are numerous risks that have the potential to adversely affect our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2022, which you can find here (a summary of the risks we can affect our business can be found on pages 39 and 40) and in our subsequent filings with the SEC, which you can access at


Jeremy WhittakerVeeva Systems

Photo - linkLogo - link

View original content: enlace